EUVIMEDEUVIMED entdecken
Open Access

The potential utility of cord blood DNA methylation in pediatric clinical practice

Stephanie W Waldrop iD, Wei Perng, Iain R Konigsberg, Sarah J Borengasser

Epigenomics · 2024

DOI: 10.1080/17501911.2024.2408217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epigenomics, 2024. Verfasst von Stephanie W Waldrop und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section on Nutrition, Department of Pediatrics, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: DNA Methylation, Epigenesis, Genetic, Fetal Blood. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our understanding of the origins of noncommunicable diseases has evolved over the years with greater consideration given to the lasting influence exposures and experiences during the preconceptional and prenatal periods can have. Research highlights the associations of parental exposures (e.g., diet, obesity, gestational diabetes, lipid profile, toxic exposures and microbiome) with the infant/fetal methylome and suggest associations with infant, child and/or adolescent chronic health outcomes. Thus, epigenetics and specifically cord blood DNA methylation may have utility as biomarkers for disease risk identification and stratification in pediatrics. However, for cord blood DNA methylation analyses to be leveraged as biomarkers of disease risk in pediatric clinical practice, the results must be replicable, validated and clinically meaningful. Challenges and opportunities to this prospect are herein discussed. [Box: see text].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationEpigenesis, GeneticFetal BloodChildFemaleHumansInfant, NewbornPregnancyBiomarkersEpigenomicsPediatricsInfantChild, PreschoolAdolescent

Stichwörter der Autor:innen

cord blood DNA methylationdevelopmental origins of health and diseaseepigenetic predictorspediatric chronic disease

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Section on Nutrition, Department of Pediatrics, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Division of Clinical Sciences, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA 70808, USA.
  • Lifecourse Epidemiology of Adiposity & Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Department of Pediatrics, TSET Health Promotion Research Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

ORCID-Profile: Stephanie W Waldrop

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Waldrop, S. W., Perng, W., Konigsberg, I. R., & Borengasser, S. J. (2024). The potential utility of cord blood DNA methylation in pediatric clinical practice. Epigenomics. https://doi.org/10.1080/17501911.2024.2408217

Vancouver

Waldrop SW, Perng W, Konigsberg IR, Borengasser SJ. The potential utility of cord blood DNA methylation in pediatric clinical practice. Epigenomics. 2024. doi:10.1080/17501911.2024.2408217

BibTeX
@article{Waldrop2024,
  author = {Waldrop, Stephanie W and Perng, Wei and Konigsberg, Iain R and Borengasser, Sarah J},
  title = {The potential utility of cord blood DNA methylation in pediatric clinical practice},
  journal = {Epigenomics},
  year = {2024},
  doi = {10.1080/17501911.2024.2408217}
}
Kostenlos starten →